IONS
Ionis Pharmaceuticals, Inc. · Healthcare
EVP Research Eric Swayze sold $1.4M of Ionis Pharmaceuticals, Inc.
Sold$1,360,081
$50.19Price
27,100Shares
−45%Stake
What IONS did after the filing
- The stock from Tue, Jan 2 close, $52.87
- −7.2%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Feb 14 close.
Traded Thu, Dec 28. Filed Tue, Jan 2, 12:54 PM ET, during the session. Returns use the Jan 2 close and the Feb 14 close. Not investment advice.